Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
ktaeWBhWf7CWDrdR